Literature DB >> 22342356

Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure.

M J Warrell1.   

Abstract

Travellers are probably the largest group in the general population to receive rabies pre-exposure prophylaxis. The dangerous consequences of the unavailability of rabies immune globulin in many countries could be ameliorated if pre-exposure rabies vaccination were practised more widely, especially in children, living in dog rabies enzootic countries. The WHO has recommended several different regimens for post-exposure prophylaxis, while individual countries decide on protocols for local use. Intramuscular regimens are expensive and waste vaccine. Although failure to receive vaccine is usually the due to the cost, the economical potential of intradermal vaccination has still not been realised 19 years after its introduction. The currently recommended 2-site intradermal post-exposure regimen is not economical for use in rural areas where 80% of Indian rabies deaths occur. Most countries using it demand higher potency vaccine, indicating that they do not have complete confidence in the method. This intradermal regimen has only been used where immunoglobulin is likely to be available for severely bitten patients. Increased intradermal doses are sometimes used for selected patients. Provision of economical rabies prophylaxis can be improved. Decisions to change recommendations should take account of the immunological, financial, practical and logistical aspects of dog bite treatment in remote areas. Copyright Â
© 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342356     DOI: 10.1016/j.tmaid.2011.12.005

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  18 in total

1.  Rabies in travelers.

Authors:  Philippe Gautret; Philippe Parola
Journal:  Curr Infect Dis Rep       Date:  2014-03       Impact factor: 3.725

Review 2.  Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies.

Authors:  Sergio Rosales-Mendoza
Journal:  Mol Biotechnol       Date:  2015-10       Impact factor: 2.695

3.  Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China.

Authors:  Quan Hu; Man-Qing Liu; Zheng-Gang Zhu; Ze-Rong Zhu; Sha Lu
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

Review 4.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 5.  Dog and cat bite-associated infections in children.

Authors:  S Esposito; I Picciolli; M Semino; N Principi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-14       Impact factor: 3.267

6.  Sudden onset unilateral sensorineural hearing loss after rabies vaccination.

Authors:  Saleh Okhovat; Richard Fox; Jennifer Magill; Antony Narula
Journal:  BMJ Case Rep       Date:  2015-12-15

Review 7.  Intrathecal humoral immunity to encephalitic RNA viruses.

Authors:  Timothy W Phares; Stephen A Stohlman; Cornelia C Bergmann
Journal:  Viruses       Date:  2013-02-15       Impact factor: 5.048

Review 8.  Vaccination in elite athletes.

Authors:  Barbara C Gärtner; Tim Meyer
Journal:  Sports Med       Date:  2014-10       Impact factor: 11.136

9.  Animal-associated exposure to rabies virus among travelers, 1997-2012.

Authors:  Philippe Gautret; Kira Harvey; Prativa Pandey; Poh Lian Lim; Karin Leder; Watcharapong Piyaphanee; Marc Shaw; Susan C McDonald; Eli Schwartz; Douglas H Esposito; Philippe Parola
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

10.  A glance at rabies pre-exposure and post-exposure prophylaxis for dog bites.

Authors:  Mirko Bertozzi; Victoria Elisa Rinaldi; Giuseppe Di Cara; Antonino Appignani
Journal:  Afr J Paediatr Surg       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.